DR. GUENTER DELPHINE financials
A multi-period view of the public annual-account figures reported for DR. GUENTER DELPHINE, with comparable measures and links to available source documents.
Company overviewRegistry number
0767419161
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for DR. GUENTER DELPHINE
2025 versus 2024
- Operating line
- €109,114
- EBITDA
- €108,570
- Total assets
- €190,668
- Equity
- €178,248
+3.2%
+3.4%
+27.9%
+92.3%
EBITDA margin +99.5% · Equity ratio +93.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €109,114 | €108,570 | €190,668 | €178,248 | - |
| 202431 Dec 2024 | €105,694 | €104,984 | €149,123 | €92,669 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.